Khallikane S et al., 2026-09-16: Narrative review of perioperative vasoplegic syndrome placing methylene blue among the non-adrenergic agents used with catecholamines in refractory cases.
Current therapeutic strategies emphasize a multimodal, physiology-guided approach combining catecholamines with non-adrenergic agents such as vasopressin, methylene blue, hydroxocobalamin, and angiotensin II, particularly in refractory cases.
Khallikane S et al., 2026-09-16: Narrative review of perioperative vasoplegic syndrome placing methylene blue among the non-adrenergic agents used with catecholamines in refractory cases. C5. Study type: narrative review (PubMed search 2020-2026 plus landmark trials); Avicenna Military Hospital, Iran (first author affiliation). No patients. Authors declare no conflicts of interest. Reports that optimal sequencing and patient selection remain uncertain. Ann Med Surg (Lond) 2026;88:6683-6688. Study type: review.
